Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine Final results from Novartis’ phase 3 SPR1NT trial assessing Zolgensma (onasemnogene abeparvovec) have been published in Nature Medicine. ... presymptomatic babies with SMA,” said Shephard Mpofu, senior vice president, chief medical officer, Novartis

Novartis announces promising five-year data for leukaemia treatment Kymriah

Novartis announces promising five-year data for leukaemia treatment Kymriah Novartis has shared long-term, five-year follow-up results from its pivotal clinical phase 2 trial, ELIANA, evaluating Kymriah (tisagenlecleucel), the first-ever approved CAR T-cell therapy, in children ... Jeff Legos, executive vice president, Novartis,

New virtual health and care report from WHO and Novartis calls for ‘critical action’

New virtual health and care report from WHO and Novartis calls for ‘critical action’ by the World Health Organization (WHO) and the Novartis Foundation (Novartis), details how the past two years have changed access to health and care in 23 countries. ... People who need help to access or navigate virtual health services, for example,

Finalists 2022

for Novartis UK. LADBible Heamophilia. by Hanover Communications. for ROCHE. My MS Space. ... by Lumanity. M&F Health. Maddy Farnworth, MHP Mischief. MHP Mischief. Novartis UK.

Novartis’ Kymriah receives FDA approval to treat follicular lymphoma

Novartis’ Kymriah receives FDA approval to treat follicular lymphoma Novartis’ Kymriah has been given accelerated approval by the US Food and Drug Administration (FDA) for adult patients diagnosed with relapsed or refractory (r/r) follicular lymphoma (FL) who have had ... treatment for patients with follicular

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....